Phase III — Prevalidation of the 3 methods subdivided into 3 lots: lot 1 - Direct Peptide Reactivity Assay (DPRA); lot 2 - Myeloid U937 Skin Sensitisation Test (MUSST); lot 3 - human Cell Line Activation Test (hCLAT)

The Institute for Health and Consumer Protection (IHCP) has launched an open call for tender, for ECVAM of the In Vitro Methods Unit. The aim of the call is to invite laboratories to participate in the initial phase (phase III prevalidation) of the evaluation of three test methods designed for the assessment of the skin sensitisation potential of substances. The three methods are: 1) the Direct Peptide Reactivity Assay, 2) the Myeloid U937 Skin Sensitisation Test (MUSST) and 3) the human Cell Line Activation Test (h-CLAT). Within this project the selected laboratories will work in close contact with multinational companies as well as the European Commission's Joint Research Centre.

Access to the official notice:

• Document no: 2009/S 166-239612 (pdf) available from the Tenders Electronic Daily Homepage

Deadline for submitting offers: 13 October 2009

Contact Address:

Further information including the relevant tender documents can be obtained from JRC-IHCP-PROCUREMENT@ec.europa.eu  Tel: +39-0332-789197; Fax: +39-0332-789434

In Vitro Methods Unit/ECVAM
Institute for Health & Consumer Protection (IHCP)
European Commission - Joint Research Centre (EC-JRC)

VOLVER